These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30024606)

  • 1. HOTTIP participates in mammary cancer by promoting cell proliferation via PI3K/AKT pathway.
    Gao W; Wu XL; Li DZ; Liu HD
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4181-4187. PubMed ID: 30024606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTTIP regulates progression of endometrial cancer via activating PI3K/AKT pathway.
    Guan Q; Zhang Q; Zhang C; Liu Q; Ren QL
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3727-3733. PubMed ID: 29949146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HOTTIP knockdown inhibits cell proliferation and migration via regulating miR-490-3p/HMGB1 axis and PI3K-AKT signaling pathway in ox-LDL-induced VSMCs.
    Guo X; Liu Y; Zheng X; Han Y; Cheng J
    Life Sci; 2020 May; 248():117445. PubMed ID: 32081664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXK1 promotes malignant progression of breast cancer by activating PI3K/AKT/mTOR signaling pathway.
    Li ZQ; Qu M; Wan HX; Wang H; Deng Q; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9978-9987. PubMed ID: 31799667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.
    Yun WK; Hu YM; Zhao CB; Yu DY; Tang JB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2786-2793. PubMed ID: 31002129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway.
    Lei Y; Wang YH; Wang XF; Bai J
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6315-6323. PubMed ID: 30338799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA PICART1 inhibits cell proliferation by regulating the PI3K/AKT and MAPK/ERK signaling pathways in gastric cancer.
    Li JF; Li WH; Xue LL; Zhang Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):588-597. PubMed ID: 30720166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.
    Sun Y; Cao FL; Qu LL; Wang ZM; Liu XY
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1459-1467. PubMed ID: 30840267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-122-5p promotes the development of non-small cell lung cancer via downregulating p53 and activating PI3K-AKT pathway.
    Fan X; Wu X
    J BUON; 2019; 24(1):273-279. PubMed ID: 30941980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of HOTTIP regulates insulin secretion and cell cycle in islet β cells via inhibiting MEK/ERK pathway.
    Xu X; Tian J; Li QY
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4962-4968. PubMed ID: 30070332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LINC00963 promotes hepatocellular carcinoma progression by activating PI3K/AKT pathway.
    Wu JH; Tian XY; An QM; Guan XY; Hao CY
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1645-1652. PubMed ID: 29630107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
    Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01170 promotes the progression of endometrial carcinoma by activating the AKT pathway.
    Zhang Z; Liu X; Xu H; Li P; Zeng T; Du W; Lu X
    J BUON; 2018; 23(6):1745-1752. PubMed ID: 30610803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTTIP promotes proliferation and cell cycle progression of acute myeloid leukemia cells.
    Zhuang MF; Li LJ; Ma JB
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2908-2915. PubMed ID: 31002141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UCA1 promotes papillary thyroid carcinoma development by stimulating cell proliferation via Wnt pathway.
    Lu HW; Liu XD
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5576-5582. PubMed ID: 30229831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
    Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
    Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Overexpression of CDHR2 inhibits proliferation of breast cancer cells by inhibiting the PI3K/Akt pathway].
    Fang J; Liu L; Lin J; Chen F
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1117-1125. PubMed ID: 38977341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.